Amiodarone-induced blue man syndrome: a case report

Area of Science:

• Cardiology
• Dermatology

Background:

• Amiodarone is a widely used antiarrhythmic medication for various arrhythmias.
• Despite its efficacy, amiodarone is associated with numerous potential side effects affecting multiple organ systems.
• Blue-gray cutaneous discoloration, or blue man syndrome, is a rare (<3%) but notable adverse effect of chronic amiodarone use.

Observation:

• A case report details a 51-year-old male with ventricular arrhythmia and cardiomyopathy on long-term amiodarone therapy.
• The patient developed a blue-gray discoloration on his face over three weeks, despite having an implantable cardioverter-defibrillator and no recent medical follow-up.
• This presentation highlights a specific cutaneous manifestation of amiodarone toxicity.

Findings:

• Blue man syndrome is an uncommon but significant side effect of amiodarone treatment.
• The condition can impact a patient's quality of life due to aesthetic concerns.
• No association was found between blue man syndrome and other amiodarone-related complications in this case.

Implications:

• Patients prescribed amiodarone must be informed about potential side effects, including blue man syndrome.
• Regular medical follow-up is crucial for patients on chronic amiodarone therapy to monitor for adverse effects.
• Healthcare providers play a critical role in managing amiodarone prescriptions, balancing therapeutic benefits with potential risks and patient well-being.